Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T13201 | Target Info | |||
Target Name | Carbonic anhydrase I (CA-I) | ||||
Synonyms |
Carbonic anhydrase B; Carbonic anhydrase 1; Carbonate dehydratase I; CAB
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | CA1 | ||||
Biochemical Class | Alpha-carbonic anhydrase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Carbonic anhydrase II (CA-II) | Successful Target | ||||
UniProt ID | CAH2_HUMAN | |||||
Gene Name | CA2 | |||||
Synonyms |
Carbonic anhydrase C; Carbonic anhydrase 2; Carbonate dehydratase II; CAC
Click to Show/Hide
|
|||||
Representative Drug(s) | Acetazolamide | Drug Info | Ki = 0.012 nM | Click to Show More | [1] | |
2 | Ethoxzolamide | Drug Info | IC50 = 0.3 nM | [3] | ||
3 | SULFAMIDE | Drug Info | Ki = 1.13 nM | [2] | ||
4 | Methazolamide | Drug Info | IC50 = 4.8 nM | [7] | ||
5 | Dichlorphenamide | Drug Info | Ki = 8 nM | [8] | ||
6 | Coumate | Drug Info | Ki = 25 nM | [13] | ||
Co-Target Name | Carbonic anhydrase VI (CA-VI) | Successful Target | ||||
UniProt ID | CAH6_HUMAN | |||||
Gene Name | CA6 | |||||
Synonyms |
Secreted carbonic anhydrase; Salivary carbonic anhydrase; Carbonic anhydrase 6; Carbonate dehydratase VI
Click to Show/Hide
|
|||||
Representative Drug(s) | SULFAMIDE | Drug Info | Ki = 0.07 nM | Click to Show More | [2] | |
2 | Methazolamide | Drug Info | Ki = 10 nM | [10] | ||
3 | Acetazolamide | Drug Info | Ki = 11 nM | [12] | ||
4 | Ethoxzolamide | Drug Info | Ki = 43 nM | [2] | ||
5 | Dichlorphenamide | Drug Info | Ki = 79 nM | [16] | ||
Co-Target Name | Carbonic anhydrase XII (CA-XII) | Successful Target | ||||
UniProt ID | CAH12_HUMAN | |||||
Gene Name | CA12 | |||||
Synonyms |
Tumor antigen HOM-RCC-3.1.3; Carbonic anhydrase 12; Carbonate dehydratase XII
Click to Show/Hide
|
|||||
Representative Drug(s) | Acetazolamide | Drug Info | Ki = 2.5 nM | Click to Show More | [4] | |
2 | Methazolamide | Drug Info | Ki = 3.4 nM | [6] | ||
3 | Ethoxzolamide | Drug Info | Ki = 22 nM | [6] | ||
4 | Dichlorphenamide | Drug Info | Ki = 50 nM | [15] | ||
Co-Target Name | Carbonic anhydrase XIV (CA-XIV) | Successful Target | ||||
UniProt ID | CAH14_HUMAN | |||||
Gene Name | CA14 | |||||
Synonyms |
UNQ690/PRO1335; Carbonic anhydrase 14; Carbonate dehydratase XIV
Click to Show/Hide
|
|||||
Representative Drug(s) | Ethoxzolamide | Drug Info | Ki = 2.5 nM | Click to Show More | [5] | |
2 | Acetazolamide | Drug Info | Ki = 5.7 nM | [1] | ||
3 | Methazolamide | Drug Info | Ki = 43 nM | [14] | ||
4 | Dichlorphenamide | Drug Info | Ki = 345 nM | [5] | ||
Co-Target Name | Steryl-sulfatase (STS) | Successful Target | ||||
UniProt ID | STS_HUMAN | |||||
Gene Name | STS | |||||
Synonyms |
Steryl-sulfate sulfohydrolase; Steroid sulfatase; STS; Estrone sulfatase; Arylsulfatase C; ASC
Click to Show/Hide
|
|||||
Representative Drug(s) | Coumate | Drug Info | IC50 = 10 uM tube-1 | [9] | ||
Co-Target Name | Carbonic anhydrase IV (CA-IV) | Successful Target | ||||
UniProt ID | CAH4_HUMAN | |||||
Gene Name | CA4 | |||||
Synonyms |
Carbonic anhydrase 4; Carbonate dehydratase IV; CAIV
Click to Show/Hide
|
|||||
Representative Drug(s) | Acetazolamide | Drug Info | Ki = 11 nM | Click to Show More | [11] | |
2 | Ethoxzolamide | Drug Info | Ki = 93 nM | [17] | ||
3 | Dichlorphenamide | Drug Info | Ki = 95 nM | [10] | ||
4 | Methazolamide | Drug Info | Ki = 240 nM | [18] | ||
5 | SULFAMIDE | Drug Info | Ki = 880 nM | [21] | ||
Co-Target Name | Amyloid beta A4 protein (APP) | Successful Target | ||||
UniProt ID | A4_HUMAN | |||||
Gene Name | APP | |||||
Synonyms |
Protease nexin-II; PreA4; PN-II; Cerebral vascular amyloid peptide; CVAP; Amyloid-beta precursor protein; Amyloid-beta A4 protein; Alzheimer disease amyloid protein; APPI; APP; AD1; ABPP; A4
Click to Show/Hide
|
|||||
Representative Drug(s) | Curcumin | Drug Info | IC50 = 630 nM | [19] | ||
Co-Target Name | Monoamine oxidase type A (MAO-A) | Successful Target | ||||
UniProt ID | AOFA_HUMAN | |||||
Gene Name | MAOA | |||||
Synonyms |
Monoamine oxidase A; Amine oxidase [flavin-containing] A
Click to Show/Hide
|
|||||
Representative Drug(s) | Curcumin | Drug Info | Ki = 710 nM | [20] | ||
Co-Target Name | Carbonic anhydrase IX (CA-IX) | Clinical trial Target | ||||
UniProt ID | CAH9_HUMAN | |||||
Gene Name | CA9 | |||||
Synonyms |
Renal cell carcinoma-associated antigen G250; RCC-associated antigen G250; PMW1; P54/58N; Membrane antigen MN; MN; G250 antigen (MN/CA IX/G250); G250; Carbonic anhydrase 9; Carbonate dehydratase IX; CAIX
Click to Show/Hide
|
|||||
Representative Drug(s) | Acetazolamide | Drug Info | Ki = 0.06 nM | Click to Show More | [1] | |
2 | Ethoxzolamide | Drug Info | IC50 = 0.25 nM | [22] | ||
3 | Methazolamide | Drug Info | IC50 = 0.25 nM | [7] | ||
4 | Dichlorphenamide | Drug Info | Ki = 34 nM | [8] | ||
Co-Target Name | Lactoylglutathione lyase (GLO1) | Clinical trial Target | ||||
UniProt ID | LGUL_HUMAN | |||||
Gene Name | GLO1 | |||||
Synonyms |
S-D-lactoylglutathione methylglyoxal lyase; Methylglyoxalase; Ketone-aldehyde mutase; Glyoxalase I; GlxI; Glx I; GLO1; Aldoketomutase
Click to Show/Hide
|
|||||
Representative Drug(s) | Curcumin | Drug Info | Ki = 5 nM | [23] | ||
Co-Target Name | Tissue factor (F3) | Successful Target | ||||
UniProt ID | TF_HUMAN | |||||
Gene Name | F3 | |||||
Synonyms |
Thromboplastin; TF; F3; Coagulation factor III; CD142 antigen
Click to Show/Hide
|
|||||
Representative Drug(s) | Curcumin | Drug Info | IC50 = 13.16 nM | [24] | ||
Co-Target Name | Prostaglandin E synthase (PTGES) | Clinical trial Target | ||||
UniProt ID | PTGES_HUMAN | |||||
Gene Name | PTGES | |||||
Synonyms |
p53-induced gene 12 protein; PIG12; PGES; PGE synthase; P53-induced apoptosis protein 12; Microsomal prostaglandin E synthase 1; Microsomal glutathione S-transferase 1-like 1; MPGES1; MPGES-1; MGST1L1; MGST1-L1
Click to Show/Hide
|
|||||
Representative Drug(s) | Curcumin | Drug Info | IC50 = 200 nM | [25] | ||
Co-Target Name | Carbonic anhydrase VII (CA-VII) | Patented-recorded Target | ||||
UniProt ID | CAH7_HUMAN | |||||
Gene Name | CA7 | |||||
Synonyms |
Carbonic anhydrase 7; Carbonate dehydratase VII
Click to Show/Hide
|
|||||
Representative Drug(s) | Ethoxzolamide | Drug Info | Ki = 0.78 nM | Click to Show More | [26] | |
2 | Acetazolamide | Drug Info | Ki = 2 nM | [27] | ||
3 | Methazolamide | Drug Info | Ki = 2.1 nM | [28] | ||
4 | Dichlorphenamide | Drug Info | Ki = 6 nM | [10] | ||
Co-Target Name | Carbonic anhydrase V (CA5) | Co-Target | ||||
UniProt ID | CAH5A_HUMAN; CAH5B_HUMAN | |||||
Gene Name | CA5A; CA5B | |||||
Synonyms |
Carbonate dehydratase V; Carbonic anhydrase V; CA-V
Click to Show/Hide
|
|||||
Representative Drug(s) | SULFAMIDE | Drug Info | Ki = 0.84 nM | Click to Show More | [29] | |
2 | Acetazolamide | Drug Info | Ki = 1.8 nM | [30] | ||
3 | Ethoxzolamide | Drug Info | Ki = 2 nM | [30] | ||
4 | Methazolamide | Drug Info | Ki = 2.5 nM | [30] | ||
Co-Target Name | Carbonic anhydrase III (CA3) | Co-Target | ||||
UniProt ID | CAH3_HUMAN | |||||
Gene Name | CA3 | |||||
Synonyms |
Carbonic anhydrase 3; Carbonate dehydratase III; CA-III
Click to Show/Hide
|
|||||
Representative Drug(s) | Methazolamide | Drug Info | Ki = 1.1 nM | Click to Show More | [14] | |
2 | Acetazolamide | Drug Info | Ki = 3.1 nM | [14] | ||
Co-Target Name | Carbonic anhydrase XIII (CA13) | Co-Target | ||||
UniProt ID | CAH13_HUMAN | |||||
Gene Name | CA13 | |||||
Synonyms |
Carbonic anhydrase 13; Carbonate dehydratase XIII; CA-XIII
Click to Show/Hide
|
|||||
Representative Drug(s) | Acetazolamide | Drug Info | Ki = 5.7 nM | Click to Show More | [5] | |
2 | Methazolamide | Drug Info | Ki = 19 nM | [33] | ||
3 | Dichlorphenamide | Drug Info | Ki = 23 nM | [33] | ||
Co-Target Name | Carbonic anhydrase-related protein 11 (CA11) | Co-Target | ||||
UniProt ID | CAH11_HUMAN | |||||
Gene Name | CA11 | |||||
Synonyms |
CA-RP XI; CA-XI; CARP XI; Carbonic anhydrase-related protein 2; CA-RP II; CARP-2
Click to Show/Hide
|
|||||
Representative Drug(s) | Acetazolamide | Drug Info | Ki = 5.7 nM | [31] | ||
Co-Target Name | Carbonic anhydrase VB (CA5B) | Co-Target | ||||
UniProt ID | CAH5B_HUMAN | |||||
Gene Name | CA5B | |||||
Synonyms |
Carbonic anhydrase 5B, mitochondrial; Carbonate dehydratase VB; Carbonic anhydrase VB; CA-VB
Click to Show/Hide
|
|||||
Representative Drug(s) | Ethoxzolamide | Drug Info | Ki = 19 nM | Click to Show More | [32] | |
2 | Dichlorphenamide | Drug Info | Ki = 21 nM | [32] | ||
3 | Acetazolamide | Drug Info | Ki = 54 nM | [34] | ||
4 | Methazolamide | Drug Info | Ki = 62 nM | [28] | ||
Co-Target Name | Carbonic anhydrase VA (CA5A) | Co-Target | ||||
UniProt ID | CAH5A_HUMAN | |||||
Gene Name | CA5A | |||||
Synonyms |
Carbonic anhydrase 5A, mitochondrial; Carbonate dehydratase VA; CA-VA
Click to Show/Hide
|
|||||
Representative Drug(s) | Ethoxzolamide | Drug Info | Ki = 25 nM | Click to Show More | [28] | |
2 | Acetazolamide | Drug Info | Ki = 60 nM | [13] | ||
3 | Methazolamide | Drug Info | Ki = 65 nM | [28] | ||
4 | Dichlorphenamide | Drug Info | Ki = 81 nM | [10] | ||
Co-Target Name | CDGSH iron-sulfur domain-containing protein 1 (CISD1_HUMAN) | Co-Target | ||||
UniProt ID | CISD1_HUMAN | |||||
Gene Name | CISD1 | |||||
Synonyms |
MitoNEET
Click to Show/Hide
|
|||||
Representative Drug(s) | Curcumin | Drug Info | Ki = 101 nM | [35] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Fluorescent sulfonamide carbonic anhydrase inhibitors incorporating 1,2,3-triazole moieties: Kinetic and X-ray crystallographic studies. Bioorg Med Chem. 2016 Jan 15;24(2):104-12. | ||||
REF 2 | Carbonic anhydrase inhibitors. Inhibition studies with anions and sulfonamides of a new cytosolic enzyme from the scleractinian coral Stylophora pistillata. Bioorg Med Chem Lett. 2011 Jan 15;21(2):710-4. | ||||
REF 3 | Discovery of new potent inhibitors for carbonic anhydrase IX by structure-based virtual screening. Bioorg Med Chem Lett. 2013 Jun 15;23(12):3496-9. | ||||
REF 4 | Coumarinyl-substituted sulfonamides strongly inhibit several human carbonic anhydrase isoforms: solution and crystallographic investigations. Bioorg Med Chem. 2010 Jul 15;18(14):4873-8. | ||||
REF 5 | Sulfonamides incorporating 1,3,5-triazine moieties selectively and potently inhibit carbonic anhydrase transmembrane isoforms IX, XII and XIV over cytosolic isoforms I and II: Solution and X-ray crystallographic studies. Bioorg Med Chem. 2011 May 15;19(10):3105-19. | ||||
REF 6 | Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties. Bioorg Med Chem. 2014 Mar 1;22(5):1586-95. | ||||
REF 7 | Optimization of heterocyclic substituted benzenesulfonamides as novel carbonic anhydrase IX inhibitors and their structure activity relationship. Eur J Med Chem. 2013 Apr;62:597-604. | ||||
REF 8 | Carbonic anhydrase inhibitors. Novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic... Bioorg Med Chem Lett. 2005 Jan 17;15(2):367-72. | ||||
REF 9 | Design, synthesis and biochemical evaluation of AC ring mimics as novel inhibitors of the enzyme estrone sulfatase (ES). Bioorg Med Chem Lett. 2002 May 20;12(10):1343-6. | ||||
REF 10 | Carbonic anhydrase inhibitors: the X-ray crystal structure of ethoxzolamide complexed to human isoform II reveals the importance of thr200 and gln92 for obtaining tight-binding inhibitors. Bioorg Med Chem Lett. 2008 Apr 15;18(8):2669-74. | ||||
REF 11 | Carbonic anhydrase inhibitors: inhibition studies of a coral secretory isoform with inorganic anions. Bioorg Med Chem Lett. 2009 Feb 1;19(3):650-3. | ||||
REF 12 | Inhibition studies of new ureido-substituted sulfonamides incorporating a GABA moiety against human carbonic anhydrase isoforms I-XIV. Bioorg Med Chem. 2014 Dec 15;22(24):6768-75. | ||||
REF 13 | Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides. Bioorg Med Chem Lett. 2005 Dec 1;15(23):5192-6. | ||||
REF 14 | Carbonic anhydrases as targets for medicinal chemistry. Bioorg Med Chem. 2007 Jul 1;15(13):4336-50. | ||||
REF 15 | Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies. Eur J Med Chem. 2018 Jan 1;143:1931-41. | ||||
REF 16 | Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. J Med Chem. 2010 Aug 12;53(15):5511-22. | ||||
REF 17 | Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mamm... Bioorg Med Chem Lett. 2010 Jun 15;20(12):3601-5. | ||||
REF 18 | Carbonic anhydrase inhibitors: synthesis of sulfonamides incorporating dtpa tails and of their zinc complexes with powerful topical antiglaucoma properties. Bioorg Med Chem Lett. 2001 Feb 26;11(4):575-82. | ||||
REF 19 | Neuritogenic activity of bi-functional bis-tryptoline triazole. Bioorg Med Chem. 2017 Feb 1;25(3):1195-1201. | ||||
REF 20 | Monoamine Oxidase Inhibitory Activity of Novel Pyrazoline Analogues: Curcumin Based Design and Synthesis. ACS Med Chem Lett. 2015 Dec 1;7(1):56-61. | ||||
REF 21 | Carbonic anhydrase inhibitors: the membrane-associated isoform XV is highly inhibited by inorganic anions. Bioorg Med Chem Lett. 2009 Feb 15;19(4):1155-8. | ||||
REF 22 | Novel benzoyl thioureido benzene sulfonamides as highly potent and selective inhibitors of carbonic anhydrase IX: optimization and bioactive studies. Med. Chem. Commun. 2018; 9:2100-2105 | ||||
REF 23 | Recent advances in the discovery and development of glyoxalase I inhibitors. Bioorg Med Chem. 2020 Feb 15;28(4):115243. | ||||
REF 24 | Microbial hydroxylation and glycosylation of pentacyclic triterpenes as inhibitors on tissue factor procoagulant activity. Bioorg Med Chem Lett. 2017 Feb 15;27(4):1026-30. | ||||
REF 25 | Targeting microsomal prostaglandin E2 synthase-1 (mPGES-1): the development of inhibitors as an alternative to non-steroidal anti-inflammatory drugs (NSAIDs). Medchemcomm. 2015;6:2081-123. | ||||
REF 26 | Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. Bioorg Med Chem Lett. 2005 Feb 15;15(4):971-6. | ||||
REF 27 | Bortezomib inhibits mammalian carbonic anhydrases. Bioorg Med Chem. 2017 Oct 1;25(19):5064-5067. | ||||
REF 28 | A thiabendazole sulfonamide shows potent inhibitory activity against mammalian and nematode alpha-carbonic anhydrases. Bioorg Med Chem Lett. 2009 Mar 1;19(5):1371-5. | ||||
REF 29 | Carbonic anhydrase inhibitors. Inhibition of the newly isolated murine isozyme XIII with anions. Bioorg Med Chem Lett. 2004 Nov 1;14(21):5435-9. | ||||
REF 30 | Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies. Bioorg Med Chem Lett. 2005 May 2;15(9):2315-20. | ||||
REF 31 | Novel sulfonamide-containing 2-indolinones that selectively inhibit tumor-associated alpha carbonic anhydrases. Bioorg Med Chem. 2017 Jul 15;25(14):3714-3718. | ||||
REF 32 | Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing inhibitors with low affinity for the ubiquitous isozyme II, exemplified by the crystal structure of the topiramate sulfamide analogue. J Med Chem. 2006 Nov 30;49(24):7024-31. | ||||
REF 33 | Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms. Bioorg Med Chem. 2011 Jun 15;19(12):3732-8. | ||||
REF 34 | Molecular cloning, characterization, and inhibition studies of the Rv1284 beta-carbonic anhydrase from Mycobacterium tuberculosis with sulfonamides and a sulfamate. J Med Chem. 2009 Apr 23;52(8):2226-32. | ||||
REF 35 | Identification of small molecules that bind to the mitochondrial protein mitoNEET. Bioorg Med Chem Lett. 2016 Nov 1;26(21):5350-5353. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.